These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 194843)

  • 41. Adjuvant and immunogenic properties of bacterial lipopolysaccharide in IgE and IgG antibody formation in mice.
    Danneman PJ; Michael JG
    Cell Immunol; 1976 Mar; 22(1):128-39. PubMed ID: 776412
    [No Abstract]   [Full Text] [Related]  

  • 42. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES; O'Hagan DT; Illum L; Redhead K
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tolerizing effect of DNP-ficoll on IgE antibody production.
    Watanabe N; Kojima S; Ovary Z
    J Immunol; 1977 Jan; 118(1):251-5. PubMed ID: 299759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.
    Agnolon V; Bruno C; Leuzzi R; Galletti B; D'Oro U; Pizza M; Seubert A; O'Hagan DT; Baudner BC
    Int J Pharm; 2015 Aug; 492(1-2):169-76. PubMed ID: 26149936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of distinct T cell subsets involved in IgM antibody response of mice by pertussis toxin from Bordetella pertussis strain Maeno.
    Kumazawa Y; Yamada A; Ohtani A; Fujisawa H; Nishimura C; Mizunoe K
    Int Arch Allergy Appl Immunol; 1984; 75(2):132-8. PubMed ID: 6206001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunoglobulin E and G responses to pertussis toxin in children immunised with adsorbed and non-adsorbed whole cell pertussis vaccines.
    Duchén K; Granström M; Hedenskog S; Blennow M; Björkstén B
    Vaccine; 1997 Oct; 15(14):1558-61. PubMed ID: 9330468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjuvant activity of the histamine-sensitizing factor of Bordetella pertussis in different strains of mice.
    Lehrer SB; Vaughan JH; Tan EM
    Int Arch Allergy Appl Immunol; 1975; 49(6):796-813. PubMed ID: 171224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Proliferation of spleen cells in response to Bordetella pertussis].
    Khorobrykh VV; Barteneva NS; Snegireva AE; Pronin AV; Merimskaia OS
    Biull Eksp Biol Med; 1983 Jul; 96(7):112-4. PubMed ID: 6307420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization.
    Raz E; Tighe H; Sato Y; Corr M; Dudler JA; Roman M; Swain SL; Spiegelberg HL; Carson DA
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5141-5. PubMed ID: 8643542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of IgE antibody production in SJL mice. IV. Interaction of primed and unprimed T cells.
    Itaya T; Ovary Z
    J Exp Med; 1979 Sep; 150(3):507-16. PubMed ID: 314487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time relationships between injection of antigen and adjuvant. 3. Adjuvancy of Bordetella pertussis given at various times after the primary antigenic stimulus.
    Finger H; Emmerling P; Plager L
    Infect Immun; 1972 May; 5(5):783-91. PubMed ID: 4344394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.
    Geurtsen J; Banus HA; Gremmer ER; Ferguson H; de la Fonteyne-Blankestijn LJ; Vermeulen JP; Dormans JA; Tommassen J; van der Ley P; Mooi FR; Vandebriel RJ
    Clin Vaccine Immunol; 2007 Jul; 14(7):821-9. PubMed ID: 17494641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of rat IgE by aerosol immunization.
    Van Hout CA; Johnson HG
    J Immunol; 1972 Mar; 108(3):834-6. PubMed ID: 4334882
    [No Abstract]   [Full Text] [Related]  

  • 55. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.
    Roberts M; Cropley I; Chatfield S; Dougan G
    Vaccine; 1993; 11(8):866-72. PubMed ID: 8356847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody response to a protein antigen (ovalbumin) in dissociated spleen cell cultures from primed mice. Evidence for a suppressive effect of antigen.
    Salaman MR; Britton S
    Immunology; 1973 Jan; 24(1):55-65. PubMed ID: 4346599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elicitation of antigen-induced primary and secondary murine IgE antibody responses in vitro.
    Marcelletti JF; Katz DH
    Cell Immunol; 1991 Jul; 135(2):471-89. PubMed ID: 2036679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rat IgE production. II. Primary and booster reaginic antibody responses following intradermal or oral immunization.
    Jarrett EE; Haig DM; McDougall W; McNulty E
    Immunology; 1976 May; 30(5):671-7. PubMed ID: 179938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reagin synthesis in inbred strains of rats.
    Murphey SM; Brown S; Miklos N; Fireman P
    Immunology; 1974 Aug; 27(2):245-53. PubMed ID: 4371117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunomodulation by Bordetella pertussis: antiviral effects.
    Winters AL; Baggett DW; Lee JD; Sloan GL; Lemmon RD; Stinson RS
    Dev Biol Stand; 1985; 61():233-40. PubMed ID: 2872109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.